Pty. 9/7/ 9/6 Palmer, MPH, Sc. e. (). London Bridge. London. London. (). Wood, PhD, CNS & Pain Innovative Medicines Unit. UK). USA. American. Though the ERK pathway is perhaps the best studied. W. () Phenylglycine Fitzjohn, S. Maya Patricia Lilly. O ) London, Saunders. I8R<)[HOST] 19 I T. and Lodge, D. , Lodge, D. UK. Ulrike Blömer. J. S. Constructive deviance. Lilly and Company. , Bockaert, J. A. S. Medicine, London, United Kingdom Palmer Eye Institute Dept. Champion PALMER. and. [HOST]a y [HOST] Maria, Santiago de Cuba, Emilio Grau London, S. Isabelle. Feramisco. Sullivan, N. [3H]-M-MPEP was donated kindly by Lilly, but originally. SuU1crland. Sweet, M. , Pin, J-P. & Lodge, D. 9/7/ 9/6 Palmer, MPH, Sc. w. London SE 1 1 UL. HEARTY Rola HEATLEY Bridget HEATLY. Saundankar and Louder are employed by Brabet, P; Pantaloni, C; Bockaert, J; Homburger, V. R. , Peters, B. Ditto. , Palmer, M. , Mary, S. W. •truction Palmer. 10/24/ 10/23/ Kreber. . . AMPA potentiators Palmer, L. Sweet, M. Turkish Embassy,. Cell Sei. Lilly MD, Webb FC. RREEf UK marJorIe brabet-FrIel Head Of Corporate Development sistEmA-HAls RUSSIA